Sorin Group To Support U.S. Ovatio ICD Launch With Expanded Sales Force
This article was originally published in The Gray Sheet
Executive Summary
The Sorin Group's cardiac rhythm management unit hopes to double its 100-rep U.S. sales force in 12-18 months as part of a strategy to expand its fledgling ICD market presence and support the ongoing U.S. rollout of its Ovatio implantable defibrillator
You may also be interested in...
People In Brief
Cooper cuts exec, seeks CEO: Robert Weiss, Cooper Companies' chief operating officer, gains responsibilities as president of CooperVision, replacing current president Gregory Fryling who leaves after 22 years at the firm. The changes are part of Cooper's continuing integration of Ocular Sciences, acquired in January 2005, as it combines its CooperVision and Cooper Companies headquarters (1"The Gray Sheet" June 12, 2006, p. 15). Weiss joined Cooper in 1977 and served as CFO from 1989 until he became COO in 2005. Prudential Equity Group analyst Larry Biegelsen has pegged Weiss as a potential successor to CEO Thomas Bender, who plans to relinquish the role, which he has held since 1995, by year-end. Cooper says it is considering both internal and external candidates...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.